Department of Urology, Institute of Urology (Laboratory of Reconstructive Urology), West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Department of Oncology, the Third People's Hospital of Chengdu, Sichuan, China.
Urology. 2022 Oct;168:64-71. doi: 10.1016/j.urology.2022.07.017. Epub 2022 Jul 25.
To pool the data of published studies using the meta-analysis method to provide high-level evidence for the use of ESPB in pain control after PCNL.
Two main stream databases, Pubmed and Embase, were used to identify potentially included studies. Primary outcomes included pain visual analogue scale (VAS) at different time points, intraoperative fentanyl use, time to first rescue analgesia and total tramadol or paracetamol consumption. Secondary outcome was defined as side effects of nausea and vomiting.
Fourteen studies were identified after database searching and 6 studies were included in the quantitative analysis. Overall, ESPB could significantly reduce the postoperative short-time (1-2 hours) and long-time (24 hours) VAS values (MD: -1.35, 95%CI: -1.71, -1.00 for short-time and MD: -0.39, 95%CI: -0.61, -0.17 for long-time) without significant heterogeneity. When it came to other primary outcomes, ESPB still showed its advantages in less intraoperative fentanyl use and total tramadol/paracetamol consumption, and longer time to first rescue analgesia. Complications were similar between groups (OR:0.90, 95%CI:0.38-2.14).
ESPB was an efficient and safe procedure for postoperative pain management in PCNL. More RCTs with larger sample size are still needed.
采用荟萃分析方法汇总已发表研究数据,为 PCNL 后 ESPB 用于疼痛控制提供高级别证据。
使用 Pubmed 和 Embase 两个主要数据库来确定可能纳入的研究。主要结局指标包括不同时间点的疼痛视觉模拟评分(VAS)、术中芬太尼用量、首次解救镇痛时间和曲马多或对乙酰氨基酚总消耗量。次要结局定义为恶心和呕吐的副作用。
数据库搜索后确定了 14 项研究,其中 6 项研究纳入定量分析。总体而言,ESPB 可显著降低术后短期(1-2 小时)和长期(24 小时)VAS 值(MD:-1.35,95%CI:-1.71,-1.00 用于短期;MD:-0.39,95%CI:-0.61,-0.17 用于长期),差异无统计学意义。在其他主要结局方面,ESPB 仍显示出术中芬太尼用量和曲马多/对乙酰氨基酚总消耗量减少以及首次解救镇痛时间延长的优势。两组并发症相似(OR:0.90,95%CI:0.38-2.14)。
ESPB 是 PCNL 术后疼痛管理的有效且安全的方法。仍需要更多具有更大样本量的 RCT 研究。